Epredia

Epredia is a global precision cancer diagnostics company that equips anatomical pathology laboratories with a comprehensive portfolio of products and services, including tissue processing, embedding, sectioning, staining, immunohistochemistry, and digital archiving. Leveraging trusted brands such as Shandon, Microm, Menzel Gläser, and Richard‑Allan Scientific, Epredia delivers reliable consumables and workflow solutions that enable pathologists to achieve high‑precision diagnoses and improve patient outcomes. Since its formation in 2019 through the acquisition of Thermo Fisher Scientific’s pathology business, Epredia has built on a legacy dating back to 1937. The company’s technology is used in millions of procedures annually, supporting cancer detection and treatment decisions worldwide. Epredia’s commitment to innovation, quality, and service makes it a preferred partner for laboratories seeking to enhance efficiency, accuracy, and patient care.